AI Revolutionizing Science & Drug Discovery #ai #biology

Profluent Bio - unlike text models trained on human feedback, protein design AI leverages direct laboratory results. This 'sequence-first' approach, fed by over a billion curated protein sequences and wet-lab validated data, enables superior protein design. #AIDrugDiscovery #proteinengineering Watch the full interview with Ali Madani (Profluent) and Nathan Benaich (Air Street Capital): https://youtu.be/Oes9W8XOELk Profluent just signed a $2.25B partnership with Eli Lilly to develop AI-designed gene editors - one of the largest deals to date between a frontier AI biology lab and big pharma. It capped a huge few weeks for AI in bio, alongside Verve's base-editing data, new scaling results on protein models, and Isomorphic Labs' latest raise. Profluent: https://www.profluent.bio Air Street Capital: https://www.airstreet.com Follow Ali: https://x.com/thisismadani Follow Nathan: https://x.com/nathanbenaich